[Federal Register Volume 84, Number 26 (Thursday, February 7, 2019)]
[Notices]
[Pages 2508-2509]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-01327]


=======================================================================
-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

Centers for Disease Control and Prevention

[30-Day-19-0571]


Agency Forms Undergoing Paperwork Reduction Act Review

    In accordance with the Paperwork Reduction Act of 1995, the Centers 
for Disease Control and Prevention (CDC) has submitted the information 
collection request titled Minimum Data Elements (MDEs) for the National 
Breast and Cervical Cancer Early Detection Program (NBCCEDP) to the 
Office of Management and Budget (OMB) for review and approval. CDC 
previously published a ``Proposed Data Collection Submitted for Public 
Comment and Recommendations'' notice on March 5, 2018 to obtain 
comments from the public and affected agencies. CDC did not receive 
comments related to the previous notice. This notice serves to allow an 
additional 30 days for public and affected agency comments.
    CDC will accept all comments for this proposed information 
collection project. The Office of Management and Budget is particularly 
interested in comments that:
    (a) Evaluate whether the proposed collection of information is 
necessary for the proper performance of the functions of the agency, 
including whether the information will have practical utility;
    (b) Evaluate the accuracy of the agencies estimate of the burden of 
the proposed collection of information, including the validity of the 
methodology and assumptions used;
    (c) Enhance the quality, utility, and clarity of the information to 
be collected;
    (d) Minimize the burden of the collection of information on those 
who are to respond, including, through the use of appropriate 
automated, electronic, mechanical, or other technological collection 
techniques or other forms of information technology, e.g., permitting 
electronic submission of responses; and
    (e) Assess information collection costs.
    To request additional information on the proposed project or to 
obtain a copy of the information collection plan and instruments, call 
(404) 639-7570 or send an email to [email protected]. Direct written comments 
and/or suggestions regarding the items contained in this notice to the 
Attention: CDC Desk Officer, Office of Management and Budget, 725 17th 
Street NW, Washington, DC 20503 or by fax to (202) 395-5806. Provide 
written comments within 30 days of notice publication.

Proposed Project

    Minimum Data Elements (MDEs) for the National Breast and Cervical 
Cancer Early Detection Program (NBCCEDP)--(OMB No. 0920-0571, exp. 12/
31/2018)--Reinstatement with Change--National Center for Chronic 
Disease Prevention and Health Promotion (NCCDPHP), Centers for Disease 
Control and Prevention (CDC)

Background and Brief Description

    CDC is requesting a Reinstatement with Change to OMB No. 0920-0571. 
Based on feedback from grantees and internal subject matter experts, 
CDC proposes use of revised minimum data elements (MDEs).
    Both breast and cervical cancers are prevalent among U.S. women--in 
2014, more than 236,000 women were diagnosed with breast cancer, and 
more than 12,000 women were diagnosed with cervical cancer. Evidence 
shows that deaths from both breast and cervical cancers can be avoided 
by increasing screening services--mammography and Pap tests--among 
women. However, screening is typically underutilized among women who 
are under- or uninsured, have no regular source of healthcare, or who 
recently immigrated to the U.S.
    Congress passed the Breast and Cervical Cancer Mortality Prevention 
Act of 1990, which directed CDC to establish the National Breast and 
Cervical Cancer Early Detection Program (NBCCEDP). The purpose of the 
NBCCEDP is to increase breast and cervical cancer screening rates among 
priority populations by funding grantees to provide breast and cervical 
cancer screening services to eligible women. CDC issued a new funding 
opportunity announcement to support a five-year cooperative agreement 
under CDC-RFA-DP17-1701. The number of grantees will increase from 67 
grantees to 70 grantees.
    CDC proposes a Reinstatement with Change to the MDEs to include 
removal of several data variables that are no longer relevant for CDC 
analyses, as well as collapsing/revising several data variables to 
reduce burden and increase clarity for respondents. The MDEs focus on: 
(1) Patient demographics, (2) breast cancer screening, (3) cervical 
cancer screening, (4) breast and cervical cancer diagnoses, (5) breast 
and cervical cancer treatment, (6) timeliness of services, and (7) 
patient navigation.
    Redesigned data elements will enable CDC to better gauge progress 
in meeting clinical service delivery processes and patient-level 
outcomes. Findings will allow CDC to assess program progress in meeting 
goals and monitor implementation activities, evaluate outcomes, and 
identify grantee technical assistance needs. In addition, data 
collected will inform program improvement and help identify successful 
activities that need to be maintained, replicated, or expanded.
    OMB approval is requested for three years. The total estimated 
annualized burden hours will decrease from 536 to 350 hours. There are 
no costs to respondents other than their time.

[[Page 2509]]



                                        Estimated Annualized Burden Hours
----------------------------------------------------------------------------------------------------------------
                                                                                     Number of    Average burden
         Type of respondents                   Form name             Number of     responses per   per response
                                                                    respondents     respondent      (in hours)
----------------------------------------------------------------------------------------------------------------
NBCCEDP Grantees....................  MDES......................              70               2          150/60
----------------------------------------------------------------------------------------------------------------


Jeffrey M. Zirger,
Acting Lead, Information Collection Review Office, Office of Scientific 
Integrity, Office of Science, Centers for Disease Control and 
Prevention (CDC).
[FR Doc. 2019-01327 Filed 2-6-19; 8:45 am]
BILLING CODE 4163-18-P